An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic

Author:

Degeling Koen12ORCID,Baxter Nancy N.2ORCID,Emery Jon3ORCID,Jenkins Mark A.4ORCID,Franchini Fanny125ORCID,Gibbs Peter67ORCID,Mann G. Bruce8ORCID,McArthur Grant910ORCID,Solomon Benjamin J.910,IJzerman Maarten J.12511ORCID

Affiliation:

1. Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences University of Melbourne Melbourne Australia

2. Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences University of Melbourne Melbourne Australia

3. Centre for Cancer Research and Department of General Practice, Faculty of Medicine, Dentistry and Health Sciences University of Melbourne Melbourne Australia

4. Centre for Epidemiology and Biostatistics, School of Population and Global Health University of Melbourne Melbourne Australia

5. Department of Cancer Research Peter MacCallum Cancer Centre Melbourne Australia

6. Division of Personalised Oncology Walter and Eliza Hall Research Institute Melbourne Australia

7. Department Medical Oncology Western Health Melbourne Australia

8. Department of Surgery University of Melbourne Melbourne Australia

9. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Australia

10. Department of Medical Oncology Peter MacCallum Cancer Centre Melbourne Australia

11. Health Technology and Services Research, Technical Medical Centre, Faculty of Behavioural, Management and Social Sciences University of Twente Enschede the Netherlands

Publisher

Wiley

Subject

Oncology,General Medicine

Reference26 articles.

1. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

2. Estimating excess mortality in people with cancer and multimorbidity in the COVID‐19 emergency;Lai A;medRxiv

3. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

4. Delay in diagnosis: the experience in Denmark

5. Practical considerations for treating patients with cancer in the COVID‐19 pandemic;Segelov E;JCO Oncol Pract

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3